DNLI denalitherapeutics.com: Expected earnings per share growth for next year

Public company logo of Denali Therapeutics Inc (DNLI)

Denali Therapeutics (DNLI) is mitigating risks by developing treatments for Parkinson's and Alzheimer's diseases in partnership with pharmaceutical behemoths. The company's EPS projections for the coming year clearly demonstrate these trends, with the current figure standing at -29.80. The business foundation consists of an elite staff of neurobiologists with a strong scientific culture, while financial stability is supported by a sufficient cash reserve and the development of a blood-brain barrier crossing platform.

DNLI - Denali Projected earnings per share increase next year over the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Denali (DNLI)

- share price and consensus valuation forecast:
Fundamental company valuation:Denali Corp, DNLI
Finished products of Denali Therapeutics Inc.

This indicator reflects the weighted average analyst assessment of earnings growth rates for the coming year, capturing the revision of the asset's fundamental value following the release of quarterly and annual reports. For Denali Therapeutics (DNLI), consensus expectations for n+1 earnings dynamics depend critically on the success of R&D projects aimed at crossing the blood-brain barrier, making this chart a key tool for monitoring investment optimism.

Main competitors

Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|HRMY - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year BHVN|AMLX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Trevi Pharma (TRVI)|Consensus forecast of earnings per share growth for next year praxismedicines.com|Net earnings per share growth forecast for next year Anavex AVXL|Consensus forecast of earnings per share growth for next year CeriBell (CBLL)|PRTA - Net earnings per share growth forecast for next year|ALEC: Net earnings per share growth forecast for next year|Annexon (ANNX) - Net earnings per share growth forecast for next year|OMER: Projected earnings per share increase next year|NGNE (neurogene.com) - Earnings growth forecast for next year|Earnings growth forecast for next year AC Immune S.A.|Expected earnings per share growth for next year VYGR (Voyager Therapeutics, Inc.)|Projected earnings per share increase next year NMRA|Net earnings per share growth forecast for next year scilexholding.com SCLX|TVGN: Projected earnings per share growth rate for next year|alphacognition.com - Earnings growth forecast for next year|Cognition Therapeutics - Projected earnings per share increase next year|IKT: Earnings growth forecast for next year|Expected earnings per share growth for next year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Coya Therapeutics (COYA)|Expected earnings per share growth for next year VTGN (Vistagen)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year